CTFA To Seek Clarity On Wrinkle Product Regulatory Status, BSE Rule
This article was originally published in The Rose Sheet
Executive Summary
The Cosmetic, Toiletry and Fragrance Association will likely submit a legal memorandum to FDA later this month supporting exclusion of wrinkle removers containing alpha hydroxy and beta hydroxy acids from OTC review, according to President Ed Kavanaugh